Avalyn Pharma (AVLN): Deerfield Management Company, L.P. opened a new position $24.1M

731K

Shares reported

0.30%

Disclosed portfolio weight

$24.1M

Reported value

Holdings as of

Jun 30, 2026

Filed

Aug 14, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jun 29, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
2. Aug 12, 2026Company filing · Form 8-K · ResultsReported its results

What came next

1. Sep 15, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On September 15, 2026 (the “Effective Date”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board of Directors (the “Board”) of Avalyn Pharma Inc. (the “Company”), the Board appointed Robert Meyer, M.D. to the Board as a Class II director for an initial term expiring at the annual meeting of stockholders in 2028.”
2. Nov 9, 2026Insider · 1 personInsiders: 2 sales (~$5.1M)
3. Nov 10, 2026Insider · 1 personInsiders: 2 sales (~$1.6M)
4. Nov 12, 2026Company filing · Form 8-K · ResultsReported its results

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Avalyn Pharma

For Avalyn Pharma, OQRO holds 4 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its AVLN page.

How this filing works

• SEC Form 13F

Other disclosures at Avalyn Pharma

• SEC Form 13F-HRNov 13, 2026
• SEC Form 4Nov 12, 2026
• SEC Form 4Nov 12, 2026
• SEC Form 4Nov 12, 2026
• SEC Form 4Nov 12, 2026
• SEC Form 13F-HRAug 14, 2026

Everything OQRO holds on this company is on its AVLN page.